PhRMA
Buying intent
23 tracked signals | Top 15 topics are below.
Attention by team
LinkedIn activity, by teamWhere PhRMA's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
16d ago
20d ago
22d ago
18d ago
12d ago
12d ago
20d ago
16d ago
22d ago
19d ago
16d ago
19d ago
16d ago
18d ago
19d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph โ including themes not shown on this page.
Who's active at PhRMA
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
Primary products / business lines
LinkedIn company profileWe represent Americaโs innovative biopharmaceutical research & biotechnology companies, advocating for policies that support the discovery of new medicines and ensure broad patient access to safe, effective treatments. PhRMA is committed to working with stakeholders in Washington, across the country and around the world to: ๐นExpand patient access to safe and effective medicines through a free
Top accounts researching PhRMA
names withheld on the public pageThese are companies whose own people brought up PhRMA unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
27 companies · 64 people are researching Pharmacy Benefits Manager (PBM)
PhRMA's own team shows 3 signals on this topic. No one outside PhRMA has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Clinical Trials4,086 cos · 17,225 people
- Patient Safety2,511 cos · 10,108 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)Leadership โ 4 people
What's been said
public posts by PhRMA's teamNo public post naming PhRMA has surfaced in the past year, so this is what PhRMA's own team is posting about publicly — their topics, in their words.
In what was certainly a first, before a Hill meeting today, the staffer leading the meeting insisted we take advantage of a photo op. I decided to roll with it, and now my whole family wants to frame the photo. Maybe thereโs a reminder here about ideas that seem crazy sometimes perhaps being great ones.
May 2026๐จ๐ฝ๐ฑ๐ฎ๐๐ฒ ๐๐ผ ๐บ๐ ๐ ๐ฎ๐ ๐ญ๐ญ ๐ฝ๐ผ๐๐: The Andes virus sequence picture from the MV Hondius outbreak has changed โ and become more complicated. Open science should not require a lawyer to interpret the download button. Pathoplexus now shows ๐๐ข๐ฏ๐ outbreak-linked genome records. Table in Comments. One Swiss full-genome sequence has been released as ๐๐ฉ๐๐ง through international sequence databases. Four others remain ๐๐ฒ๐๐๐ฟ๐ถ๐ฐ๐๐ฒ๐ฑ-๐๐๐ฒ ๐๐จ๐ซ ๐ผ๐ป๐ฒ ๐๐ฒ๐ฎ๐ฟ under Pathoplexusโs outbreakโdataset policy. That split is the issue. Same outbreak. Same urgent public-health questions. Different legal status for different genomes. A journal editor or diagnostics company may be unsure whether they can incorporate all five genomes into analyses, figures, or assays without chasing bespoke permissions. For a small outbreak dataset, every genome matters. None are really โbackground.โ Each may be central to understanding transmission, linkage, and risk. So public-health agencies, academic researchers, journals, and commercial responders are left asking: what can be used freely, what requires permission, and what is safe to publish or build on? ๐๐ซ๐๐๐ข๐ญ ๐๐ง๐ ๐๐ญ๐ญ๐ซ๐ข๐๐ฎ๐ญ๐ข๐จ๐ง ๐๐จ๐ซ ๐๐๐ญ๐ ๐ ๐๐ง๐๐ซ๐๐ญ๐จ๐ซ๐ฌ ๐๐ซ๐ ๐๐ฌ๐ฌ๐๐ง๐ญ๐ข๐๐ฅ. But during an outbreak, sequence data should be not only visible โ it should be ๐ฐ๐น๐ฒ๐ฎ๐ฟ๐น๐ ๐๐๐ฎ๐ฏ๐น๐ฒ.
May 2026Congratulations Emily on an insightful article and continuing to champion the need for incentives to accelerate novel antibiotic R&D.
May 2026Even as Hib disease has fallen from view, protecting children from lifeโthreatening meningitis and pneumonia still depends on strong Hib vaccination as part of routine schedules, starting at birth with the HepB birth dose. This new brief highlights why sustaining high Hib coverage in childhood immunization programsโalongside timely birthโdose vaccinationโremains essential to prevent a resurgence of severe, vaccineโpreventable infections in young children. https://lnkd.in/edEYnkWw
May 2026Nearly one in four adults experienced a mental health condition in the past year, including more than 30% of young adults. Yet less than half of those living with these conditions receive treatment. Medications, often combined with therapy, help many, but too many people are suffering untreated. During Mental Health Awareness Month, we should be focused on expanding access, reducing stigma and ensuring patients can get the care they need when they need it. https://ow.ly/lXNS50YYg0V
May 2026